Close Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$453K Hold
7,219
0.01% 105
2025
Q4
$688K Hold
7,219
0.02% 94
2025
Q3
$705K Sell
7,219
-100
-1% -$10.4K 0.02% 92
2025
Q2
$786K Hold
7,319
0.02% 88
2025
Q1
$738K Buy
7,319
+635
+10% +$63.9K 0.02% 87
2024
Q4
$597K Hold
6,684
0.02% 97
2024
Q3
$560K Sell
6,684
-77
-1% -$6.07K 0.02% 98
2024
Q2
$521K Sell
6,761
-1,330
-16% -$97.3K 0.02% 97
2024
Q1
$554K Sell
8,091
-205
-2% -$13.2K 0.02% 93
2023
Q4
$480K Buy
8,296
+671
+9% +$35.8K 0.02% 89
2023
Q3
$403K Buy
7,625
+4,190
+122% +$220K 0.02% 90
2023
Q2
$186K Buy
3,435
+2,065
+151% +$108K 0.01% 109
2023
Q1
$69K Buy
+1,370
New +$64.6K ﹤0.01% 133

Other funds holding BSX

Close Asset Management's BSX Position: Q1 2026 in Review

Close Asset Management held its Boston Scientific (BSX) position steady in Q1 2026 at 7,219 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #105.

Close Asset Management first reported a position in BSX in Q1 2023 and has held it in 13 quarters since. The position peaked at $786K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Close Asset Management held 7,219 shares of Boston Scientific worth $453K as of Q1 2026.
  • Close Asset Management left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up 0.01% of Close Asset Management's portfolio in Q1 2026, its #105 holding.
  • Close Asset Management first reported a position in Boston Scientific in Q1 2023 and has held it in 13 quarters since.
  • Close Asset Management's Boston Scientific position peaked at $786K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.